Day: March 24, 2021

– Initial data from Phase 1/2a trial of EOS-448 to be presented at American Association for Cancer Research Annual Meeting. Company to hold conference call at 8:00 am on April 12thto discuss results – – Updated, single-agent data of inupadenant (EOS-850) from Phase 1/2a trial and initial pembrolizumab combination data are expected to be reported later in 2021 – – Strong cash balance of $336.3M allows company to rapidly advance clinical programs and continue to invest in discovery efforts to expand pipeline – CAMBRIDGE, Mass. and GOSSELIES, Belgium, March 24, 2021 (GLOBE NEWSWIRE) — iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients, today reported financial results for the...

2020 marked a year of successful evolution to a chemoprotection oncology company focused on fundamentally transforming the experience of chemotherapy for cancer patients—Advancing selective chemoprotection via p53 biomarker strategy; 50% of all cancer patients across multiple tumor types have a p53 mutationAchieved clinical proof-of-concept in Phase 1b study of ALRN-6924 in p53-mutated small cell lung cancer (SCLC) Aileron’s strategy is to ultimately pursue a tumor-agnostic indication—On track to initiate new Phase 1b placebo-controlled trial of ALRN-6924 in patients with advanced p53-mutated non-small cell lung cancer (NSCLC) in second quarter 2021Planned data readouts: Interim data end of 2021; Topline results mid-2022—Aggregate proceeds of $55.7 million from equity fundraises in the first quarter...

LONDON, March 24, 2021 (GLOBE NEWSWIRE) — Global Ship Lease, Inc. (NYSE:GSL) (the “Company”) filed its Annual Report on Form 20-F on March 19, 2021 for the year ended December 31, 2020 (the “Form 20-F”) with the U.S. Securities and Exchange Commission (the “SEC”). In compliance with the New York Stock Exchange rules, a copy of the Form 20-F can be found under the Investor Relations section (Annual Reports) of the Company’s website at http://www.globalshiplease.com. Shareholders may request a hard copy of the audited financial statements free of charge by contacting the Company at info@globalshiplease.com or by writing to Global Ship Lease, Inc., care of Global Ship Lease Services Limited, 25 Wilton Road, London, SW1V 1LW, United Kingdom or by telephoning The IGB Group at +1-646-673-9701. About...

SAN RAMON, Calif., March 24, 2021 (GLOBE NEWSWIRE) — CooperCompanies (NYSE: COO) announced today that its Board of Directors elected Robert S. Weiss as Chairman of the Board and William A. Kozy as Vice Chairman and Lead Director. Both appointments are effective March 23, 2021. “Bob and Bill’s broad management experience and deep knowledge of the medical device industry is incredibly valuable as we continue to grow the business,” said Al White, Cooper’s President and CEO. “I look forward to working closely with them in their new roles to ensure Cooper continues to have a positive impact on all our stakeholders.” Mr. Weiss has served on the CooperCompanies Board since 1996. He succeeds A. Thomas Bender as Chairman of the Board. After a long and distinguished career with Cooper, which included serving as President and CEO from 1995...

FREMONT, Calif., March 24, 2021 (GLOBE NEWSWIRE) — Concentrix Corporation (NASDAQ: CNXC), a leading global provider of customer experience (CX) solutions and technology, today announced financial results for the first quarter ended February 28, 2021.  Three Months Ended      February 28,2021   February 29,2020   ChangeRevenue ($M) $ 1,353.3     $ 1,188.6      13.9 %Operating income ($M) $ 134.9     $ 88.2      52.9 %Non-GAAP operating income ($M) (1) $ 176.6     $ 144.8      22.0 %Operating margin 10.0 %   7.4  %   260 bpsNon-GAAP operating margin (1) 13.1 %   12.2  %   90 bpsNet income ($M) $ 88.8     $ 52.3      69.8 %Non-GAAP net income ($M) (1) $ 120.0     $ 95.4      25.8 %Adjusted EBITDA ($M) (1) $ 212.6     $ 176.5      20.5 %Adjusted EBITDA margin (1) 15.7 %   14.8  %   90 bpsDiluted earnings...

VANCOUVER, Colombie-britannique, 24 mars 2021 (GLOBE NEWSWIRE) — Monument Mining Limited (TSX-V : MMY et FSE : D7Q1) « Monument » ou la « Société » est heureuse d’annoncer la nomination de M. Chris Leighton au poste de Directeur financier par intérim avec effet immédiat alors que M. Luther Nip a démissionné pendant la période de transition. « Je suis très heureux de faire part de la nomination de Chris Leighton au poste de Directeur financier de la Société et lui souhaite la bienvenue au sein de notre équipe de direction, alors que la Société lance la construction de flottation en tant que première phase du projet de sulfure aurifère à la mine d’or Selinsing en Malaisie et en Australie-occidentale », a indiqué Cathy Zhai, Présidente et PDG de Monument Mining : « J’ai la certitude que sa vaste expérience pratique...

VANCOUVER, British Columbia, March 24, 2021 (GLOBE NEWSWIRE) — Monument Mining Limited (TSX-V: MMY und FSE: D7Q1), „Monument“ oder das „Unternehmen“, gibt die Ernennung von Chris Leighton zum Interims-CFO mit sofortiger Wirkung bekannt. Luther Nip ist in der Übergangszeit zurückgetreten. „Ich freue mich sehr, die Ernennung von Chris Leighton zum CFO bekanntzugeben und ihn in unserem Managementteam willkommen zu heißen – und das zu einem Zeitpunkt, an dem das Unternehmen im Rahmen der ersten Phase des Goldsulfid-Projekts in der Goldmine Selinsing in Malaysia und Westaustralien den Bau der Flotationsanlage initiiert“, so Cathy Zhai, President und CEO von Monument Mining. „Ich bin überzeugt, dass seine umfangreiche praktische Erfahrung im Bereich Rechnungswesen und Finanzierung in der Fertigungsbranche dem Unternehmen sehr zugutekommen...

Press ReleaseMarch 24, 2021 – N° 7 SCOR condemns a deceitful and groundless move by the Covéa Group, three months before the criminal proceedings directed against Covéa and Thierry Derez SCOR was astonished to learn that Covéa has filed, “on behalf of SCOR“, a complaint against Denis Kessler. SCOR wonders what led Covéa to file this complaint, more than 2 years after it became aware of the facts it pretends to report. The facts mentioned by Covéa in its press release, namely the expenses that SCOR was obliged to incur to defend itself against Covéa’s unsolicited takeover attempt on SCOR in 2018, as well as the extra costs incurred by SCOR in connection with the implementation of its share buy-back program, are perfectly justified and legitimate, and are in no way new revelations:They were brought forward by SCOR...